Guardion Health Sciences (GHSI) Revenue & Revenue Breakdown
Guardion Health Sciences Revenue Highlights
Latest Revenue (Y)
$12.25M
Latest Revenue (Q)
$36.35K
Main Segment (Y)
Vision Testing Diagnotics
Main Geography (Y)
Vision Testing Diagnotics
Guardion Health Sciences Revenue by Period
Guardion Health Sciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $12.25M | 10.85% |
| 2022-12-31 | $11.05M | 52.77% |
| 2021-12-31 | $7.23M | 282.74% |
| 2020-12-31 | $1.89M | 109.30% |
| 2019-12-31 | $902.94K | -4.16% |
| 2018-12-31 | $942.15K | 115.42% |
| 2017-12-31 | $437.35K | 210.11% |
| 2016-12-31 | $141.03K | 25.01% |
| 2015-12-31 | $112.81K | - |
Guardion Health Sciences generated $12.25M in revenue during NA 2023, up 10.85% compared to the previous quarter, and up 1300.06% compared to the same period a year ago.
Guardion Health Sciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $36.35K | -98.79% |
| 2024-03-31 | $3.00M | 2.17% |
| 2023-12-31 | $2.94M | -12.03% |
| 2023-09-30 | $3.34M | 19.62% |
| 2023-06-30 | $2.79M | -12.43% |
| 2023-03-31 | $3.19M | 16.85% |
| 2022-12-31 | $2.73M | 2.36% |
| 2022-09-30 | $2.66M | -18.68% |
| 2022-06-30 | $3.28M | 37.35% |
| 2022-03-31 | $2.38M | -9.24% |
| 2021-12-31 | $2.63M | -16.55% |
| 2021-09-30 | $3.15M | 157.30% |
| 2021-06-30 | $1.22M | 424.53% |
| 2021-03-31 | $233.30K | 16.63% |
| 2020-12-31 | $200.02K | -21.00% |
| 2020-09-30 | $253.19K | -78.74% |
| 2020-06-30 | $1.19M | 384.66% |
| 2020-03-31 | $245.72K | 3.13% |
| 2019-12-31 | $238.27K | 47.84% |
| 2019-09-30 | $161.16K | -38.25% |
| 2019-06-30 | $260.97K | 7.60% |
| 2019-03-31 | $242.54K | 3.60% |
| 2018-12-31 | $234.11K | -20.43% |
| 2018-09-30 | $294.23K | 33.27% |
| 2018-06-30 | $220.78K | 14.37% |
| 2018-03-31 | $193.04K | -25.39% |
| 2017-12-31 | $258.74K | 312.68% |
| 2017-09-30 | $62.70K | 4.54% |
| 2017-06-30 | $59.98K | 7.21% |
| 2017-03-31 | $55.94K | 14.55% |
| 2016-12-31 | $48.83K | 45.01% |
| 2016-09-30 | $33.68K | 14.61% |
| 2016-06-30 | $29.38K | 0.86% |
| 2016-03-31 | $29.13K | - |
Guardion Health Sciences generated $36.35K in revenue during Q2 2024, up -98.79% compared to the previous quarter, and up 1.14% compared to the same period a year ago.
Guardion Health Sciences Revenue Breakdown
Guardion Health Sciences Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 18 |
|---|---|
| Vision Testing Diagnotics | $609.36K |
| Corporate Segment | - |
| Medical Foods | $332.80K |
Guardion Health Sciences's latest annual revenue breakdown by segment (product or service), as of Dec 18: Vision Testing Diagnotics (64.68%), and Medical Foods (35.32%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Sep 21 | Mar 20 | Mar 19 | Sep 18 | Jun 18 | Mar 18 |
|---|---|---|---|---|---|---|---|
| Nutritional Supplements | - | - | - | - | - | - | - |
| Diagnostics Equipment | - | $39.09K | - | - | - | - | - |
| Clinical Nutrition | - | $3.11M | - | - | - | - | - |
| Other | - | - | $14.74K | - | - | - | - |
| Vision Testing Diagnostics | - | - | - | $142.60K | - | - | - |
| Medical Foods | - | - | - | $99.93K | - | - | - |
| VectorVision medical devices and supplies | - | - | - | - | $208.15K | $140.78K | $120.90K |
| Lumega-Z and supplements | - | - | - | - | $86.08K | $79.99K | $72.14K |
Guardion Health Sciences Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 18 |
|---|---|
| Corporate Segment | - |
| Vision Testing Diagnotics | $609.36K |
| Medical Foods | $332.80K |
Guardion Health Sciences's latest annual revenue breakdown by geography, as of Dec 18: Vision Testing Diagnotics (64.68%), and Medical Foods (35.32%).
Quarterly Revenue by Country
| Country | Sep 21 | Mar 20 | Mar 19 | Sep 18 | Jun 18 | Mar 18 |
|---|---|---|---|---|---|---|
| Clinical Nutrition | $3.11M | - | - | - | - | - |
| Diagnostics Equipment | $39.09K | - | - | - | - | - |
| Other | - | $14.74K | - | - | - | - |
| Vision Testing Diagnostics | - | - | $142.60K | - | - | - |
| Medical Foods | - | - | $99.93K | - | - | - |
| VectorVision medical devices and supplies | - | - | - | $208.15K | $140.78K | $120.90K |
| Lumega-Z and supplements | - | - | - | $86.08K | $79.99K | $72.14K |
Guardion Health Sciences's latest quarterly revenue breakdown by geography, as of Sep 21: Clinical Nutrition (98.76%), and Diagnostics Equipment (1.24%).
Guardion Health Sciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PTPI | Petros Pharmaceuticals | $5.82B | $1.39M |
| ORGO | Organogenesis | $433.14M | $130.23M |
| LFCR | Lifecore Biomedical | $128.26M | $35.70M |
| AQST | Aquestive Therapeutics | $50.58M | $20.10M |
| IMCC | IM Cannabis | $48.80M | $12.06M |
| QLI | Qilian Group | $46.47M | $17.31M |
| TKNO | Alpha Teknova | $36.68M | $9.61M |
| BFRI | Biofrontera | $34.01M | $7.83M |
| UPC | Universe Pharmaceuticals | $32.31M | $13.84M |
| AGRX | Agile Therapeutics | $19.59M | $5.58M |
| GHSI | Guardion Health Sciences | $12.25M | $36.35K |
| EVOK | Evoke Pharma | $5.18M | $1.74M |
| ADMP | Adamis Pharmaceuticals | $4.76M | $9.06M |
| AKAN | Akanda | $2.16M | $762.61K |
| CYTH | Cyclo Therapeutics | $1.08M | $123.10K |
| ACRX | Talphera | $651.00K | $117.00K |
| SHPH | Shuttle Pharmaceuticals | - | - |
GHSI Revenue FAQ
What is Guardion Health Sciences’s yearly revenue?
Guardion Health Sciences's yearly revenue for 2023 was $12.25M, representing an increase of 10.85% compared to 2022. The company's yearly revenue for 2022 was $11.05M, representing an increase of 52.77% compared to 2021. GHSI's yearly revenue for 2021 was $7.23M, representing an increase of 282.74% compared to 2020.
What is Guardion Health Sciences’s quarterly revenue?
Guardion Health Sciences's quarterly revenue for Q2 2024 was $36.35K, a -98.79% decrease from the previous quarter (Q1 2024), and a -98.70% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $3M, a 2.17% increase from the previous quarter (Q4 2023), and a -5.84% decrease year-over-year (Q1 2023). GHSI's quarterly revenue for Q4 2023 was $2.94M, a -12.03% decrease from the previous quarter (Q3 2023), and a 7.68% increase year-over-year (Q4 2022).
What is Guardion Health Sciences’s revenue growth rate?
Guardion Health Sciences's revenue growth rate for the last 3 years (2021-2023) was 69.34%, and for the last 5 years (2019-2023) was 1256.52%.
What are Guardion Health Sciences’s revenue streams?
Guardion Health Sciences's revenue streams in c 18 are Vision Testing Diagnotics, and Medical Foods. Vision Testing Diagnotics generated $609.36K in revenue, accounting 64.68% of the company's total revenue Medical Foods generated $332.8K in revenue, accounting 35.32% of the company's total revenue
What is Guardion Health Sciences’s main source of revenue?
For the fiscal year ending Dec 18, the largest source of revenue of Guardion Health Sciences was Vision Testing Diagnotics. This segment made a revenue of $609.36K, representing 64.68% of the company's total revenue.